The Technical Analyst
RenovaCare, Inc. [RCAR]
Exchange: PNK Industry: Biotechnology
RenovaCare, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.00% $0.0300
America/New_York / 30 apr 2024 @ 16:04
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 2.62 mill |
| EPS: | -0.0600 |
| P/E: | -0.500 |
| Earnings Date: | N/A |
| SharesOutstanding: | 87.35 mill |
| Avg Daily Volume: | 0.0006 mill |
| RATING 2024-04-30 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Sell | |
| Return On Asset: | Neutral | |
| DE: | Sell | |
| P/E: | Neutral | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Gr.Profit | n/a | n/a | n/a | n/a | ||
| Ebit | n/a | n/a | n/a | |||
| Asset | n/a | n/a | n/a | |||
| Debt | n/a | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.500 | sector: PE -11.58 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE -0.500 | industry: PE -107.25 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.0300 - 0.0300 ( +/- 0.00%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2016-03-16 | Kirkland Kenneth | Buy | 50 000 | Stock Option |
| 2015-03-16 | Bold Thomas | Buy | 60 000 | Stock Option |
| 2016-03-16 | Rosen Rhonda Beth | Buy | 20 000 | Stock Option |
| 2016-03-16 | Sierchio Joseph | Buy | 50 000 | Stock Option |
| 2016-02-02 | Rayat Harmel S | Buy | 2 173 913 | Common stock, par value $0.00001 |
| INSIDER POWER |
|---|
| 0.00 |
| Last 54 transactions |
| Buy: 63 980 713 | Sell: 73 168 913 |
Forecast:
01:40 - $0.0010
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $0.0300 (0.00% ) |
| Volume | 0.0001 mill |
| Avg. Vol. | 0.0006 mill |
| % of Avg. Vol | 15.97 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For RCAR
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
RCAR
RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System, a treatment methodology for cell isolation for the regeneration of human skin cells; and SkinGun, a solution sprayer device for delivering the cells to the treatment area. RenovaCare, Inc. has a strategic collaboration StemCell Systems GmbH for isolating and spraying self-donated stem cells to regenerate tissues and organs. The company was formerly known as Janus Resources, Inc. and changed its name to RenovaCare, Inc. in January 2014. RenovaCare, Inc. is based in Scottsdale, Arizona.
Latest Press Releases
2022-05-03 10:06:00 - Press Release
Renovacare Announces Termination Of Stemcell Systems R&d Agreement
Scottsdale, ariz., may 03, 2022 (globe newswire) -- renovacare, inc. (symbol: rcar; www.renovacareinc.com), a clinical-stage developer of patented technologies for isolating and spraying cells for the regeneration of skin and other organs and tissues, today announced the termination of its july 1, 2020 strategic research and development agreement with stemcell systems gmbh (scs) and the closure of the renovacare r&d innovation center in berlin, germany. this decision ceases on-going development of the prototype for the closed, automated cell isolation device and the portable, disposable skingun™ spray device. development may resume at scs or other contract manufacturing organizations, upon the availability of adequate funds.
2022-04-14 18:19:00 - Press Release
Shareholder Alert: Rigrodsky Law, P.a. Is Investigating Renovacare, Inc.
Wilmington, delaware--(newsfile corp. - april 14, 2022) - rigrodsky law, p.a. is investigating potential claims against the officers and directors of renovacare, inc. (otc pink: rcar) on behalf of stockholders.to learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-renovacare-inc.to contact seth d. rigrodsky or gina m. serra cost free, call or text (302) 295-5310 or email info@rl-legal.com.rigrodsky law, p.a., with offices in delaware and new york, has recovered hundreds of millions of dollars on...
2022-03-24 08:30:00 - Press Release
Renovacare Announces Management Changes
Scottsdale, ariz., march 24, 2022 (globe newswire) -- renovacare, inc. (symbol: rcar; www.renovacareinc.com), a clinical-stage developer of patented technologies for isolating and spraying cells for the regeneration of skin and other organs and tissues, today announced reductions in its management team to further streamline administrative expenses.
2022-03-09 15:35:00 - Press Release
Renovacare Provides Clinical And Corporate Update
Scottsdale, ariz., march 09, 2022 (globe newswire) -- renovacare, inc. (symbol: rcar; www.renovacareinc.com), a clinical-stage developer of patented technologies for isolating and spraying cells for the regeneration of skin and other organs and tissues, today announced that following the review of its research and corporate activities, the company is taking steps to streamline its clinical, research and development, and administrative operations in order to reduce costs.
2022-02-03 12:30:00 - Press Release
Rm Law Announces Investigation Of Renovacare, Inc.
Berwyn, pa. , feb. 3, 2022 /prnewswire/ -- rm law, p.c.
Latest News
2021-09-16 07:10:00 - PRNewsWire
RCAR Long-Term Investor Alert: Did You Acquire RenovaCare, Inc. Before August 14, 2017? Should Management be Held Accountable for Investors Losses?
SAN DIEGO, Sept. 16, 2021 /PRNewswire/ -- Johnson Fistel, LLP is investigating potential claims on behalf of RenovaCare, Inc. (OTC: RCAR) against certain of its officers and directors.
2021-09-14 10:00:00 - Newsfile Corp
Last Few Hours to Actively Participate: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of RenovaCare, Inc. (RCAR) Class Action and Lead Plaintiff Deadline: September 14, 2021
New York, New York--(Newsfile Corp. - September 14, 2021) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against RenovaCare, Inc. (OTC Pink: RCAR) ("RenovaCare" or "the Company") and certain of its officers, on behalf of shareholders who purchased or otherwise acquired RenovaCare securities between August 14, 2017 and May 28, 2021, inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site:...
2021-09-14 09:44:00 - Newsfile Corp
RCAR Final Deadline Today: Rosen, Leading Trial Attorneys, Encourages RenovaCare, Inc. Investors with Losses to Secure Counsel Before Important September 14 Deadline in Securities Class Action - RCAR
New York, New York--(Newsfile Corp. - September 14, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of RenovaCare, Inc. (OTC Pink: RCAR) between August 14, 2017 and May 28, 2021, inclusive (the "Class Period") of the important September 14, 2021 lead plaintiff deadline.SO WHAT: If you purchased RenovaCare securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees...
2021-09-14 09:24:00 - Newsfile Corp
DEADLINE TODAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against RenovaCare, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Los Angeles, California--(Newsfile Corp. - September 14, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against RenovaCare, Inc. ("RenovaCare" or "the Company") (OTC Pink: RCAR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between August 14, 2017 and May 28, 2021, inclusive...
2021-09-13 09:19:00 - Newsfile Corp
DEADLINE TOMORROW: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against RenovaCare, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Los Angeles, California--(Newsfile Corp. - September 13, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against RenovaCare, Inc. ("RenovaCare" or "the Company") (OTC Pink: RCAR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between August 14, 2017 and May 28, 2021, inclusive...
2021-09-10 19:58:00 - PRNewsWire
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against RenovaCare, Inc. (RCAR)
2021-09-10 18:35:00 - Newsfile Corp
RenovaCare Class Action Reminder
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In RenovaCare To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - September 10, 2021) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against RenovaCare, Inc ("RenovaCare" or the "Company") (OTC Pink: RCAR) and reminds investors of the September 14, 2021 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. If you suffered losses exceeding $50,000 investing in RenovaCare stock or options...
2021-09-10 11:45:00 - Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against RenovaCare, Inc. (RCAR)
LOS ANGELES--(BUSINESS WIRE)---- $RCAR #investors--The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against RenovaCare, Inc. (RCAR)
2021-09-10 09:19:00 - Newsfile Corp
TUESDAY DEADLINE NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against RenovaCare, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Los Angeles, California--(Newsfile Corp. - September 10, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against RenovaCare, Inc. ("RenovaCare" or "the Company") (OTC Pink: RCAR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between August 14, 2017 and May 28, 2021, inclusive...
2021-09-09 09:12:00 - Newsfile Corp
TUESDAY DEADLINE REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against RenovaCare, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Los Angeles, California--(Newsfile Corp. - September 9, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against RenovaCare, Inc. ("RenovaCare" or "the Company") (OTC Pink: RCAR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between August 14, 2017 and May 28, 2021, inclusive...